In particular, MMP-9 levels were higher in relapsing remitting as compared to progressive MS (11) and active MMP-2 and MMP-9 were reciprocally associated to disease remission and activity, respectively (12, 13). This evidence concerns the gene MMP9 and myeloid sarcoma.